Burosumab is a monoclonal antibody used to treat X-linked hypophosphatemia (XLH) in adults and children. XLH is a genetic disorder that causes an abnormally low concentration of phosphate in the blood, which can lead to weakened bones, skeletal deformities, and stunted growth. Burosumab works by blocking the action of a protein called fibroblast growth factor 23 (FGF23), which is responsible for regulating phosphate levels. By blocking FGF23 activity, Burosumab helps to restore normal phosphate levels in the body and reduce the symptoms of XLH.
Burosumab, also known by the brand name Crystexia, is a medication used to treat X-linked hypophosphatemia (XLH). Here's a breakdown of its key aspects:
Purpose:
- Treats X-linked hypophosphatemia (XLH): XLH is a rare genetic disorder characterized by low levels of phosphate in the blood. Phosphate is a mineral essential for various bodily functions, including bone development, muscle function, and energy production. In individuals with XLH, a faulty gene disrupts the normal regulation of phosphate reabsorption in the kidneys, leading to excessive phosphate loss in the urine and low blood phosphate levels.
How it works:
- Replaces FGF23 protein: Burosumab is a monoclonal antibody, a laboratory-produced molecule designed to target a specific protein. In the case of XLH, burosumab targets a protein called fibroblast growth factor 23 (FGF23). FGF23 normally plays a role in regulating phosphate levels. However, in individuals with XLH, the faulty gene leads to excessive production of FGF23, contributing to phosphate loss. Burosumab binds to FGF23, blocking its activity and thereby promoting phosphate reabsorption by the kidneys, helping to increase blood phosphate levels.
Important information:
- Available by prescription: Burosumab is only available with a doctor's prescription and should be administered by a healthcare professional. It is typically given as an injection under the skin (subcutaneous injection) at regular intervals, usually every two weeks.
- Dosage and duration: The dosage and duration of treatment will be determined by your doctor based on your individual needs and response to the medication.
- Potential side effects: Common side effects of burosumab can include:
- Injection site reactions: Pain, redness, swelling, or itching at the injection site.
- Headache
- Fatigue
- Diarrhea
- Joint pain
- Warnings and precautions: There are important warnings and precautions to consider when using burosumab, including:
- Allergic reactions: Individuals with a history of severe allergic reactions to burosumab or its components should not use the medication.
- Monitoring: Regular blood tests are necessary to monitor phosphate levels and other electrolytes while using burosumab.
- Pregnancy and breastfeeding: The safety and effectiveness of burosumab in pregnant or breastfeeding women are not fully established. It's crucial to discuss the risks and benefits with your doctor if you are pregnant or breastfeeding.
- Long-term effects: The long-term effects of burosumab are still being studied.
It is important to note that:
- This information is not a substitute for professional medical advice. If you have questions or concerns about burosumab or XLH, it is crucial to consult your doctor.
- They can provide you with accurate and individualized information about the potential risks and benefits of burosumab in the context of your specific condition and medical history.
- Early diagnosis and treatment of XLH are crucial to prevent complications like bone deformities, growth problems, and muscle weakness.